Biblio Discovery — Demo Discovery Service

12 hasil untuk "Devis Pascut"

Menampilkan 1–12 · 0,29 detik · RSS

  1. Artikel Jurnal

    Recent Hints on the Dual Role of Discs Large MAGUK Scaffold Protein 5 in Cancers and in Hepatocellular Carcinoma

    Chiara Andolfi; Claudio Tiribelli; Devis Pascut

    Frontiers in Bioscience-Landmark, Vol. 27 No. 5 · 2022 · Inggris · DOAJ Scopus

    Discs large MAGUK scaffold protein 5 (DLG5) is a multi-domain member of membrane-associated guanylate kinase (MAGUK) family, which plays a major role in the maintenance of cell epithelial polarity being part of the SCRIB-LGL-DLG complex. Although polarity proteins have been generally considered…

  2. Artikel Jurnal

    Silencing efficacy prediction: a retrospective study on target mRNA features

    Devis Pascut; Giorgio Bedogni; Claudio Tiribelli

    Bioscience Reports, Vol. 35 No. 2 · 2015 · Inggris · DOAJ Scopus

    Post-transcriptional gene silencing is a widely used method to suppress gene expression. Unfortunately only a portion of siRNAs do successfully reduce gene expression. Target mRNA secondary structures and siRNA-mRNA thermodynamic features are believed to contribute to the silencing activity…

  3. Artikel Jurnal

    Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care

    Inah Marie C. Aquino; Devis Pascut

    Annals of Hepatology, Vol. 29 No. 2 · 2024 · Inggris · DOAJ Scopus

    Liquid biopsy, specifically the analysis of circulating tumor DNA (ctDNA), offers a non-invasive approach for hepatocellular carcinoma (HCC) diagnosis and management. However, its implementation in the clinical setting is difficult due to challenges such as low ctDNA yield and difficulty in…

  4. Artikel Jurnal Teks lengkap

    The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges

    Clarissa Joy C. Garcia; Luca Grisetti; Claudio Tiribelli dkk.

    Life, Vol. 14 No. 11 · 2024 · Inggris · DOAJ Scopus

    Hepatocellular carcinoma (HCC) represents a major public health concern and ranks among the leading cancer-related mortalities globally. Due to the frequent late-stage diagnosis of HCC, therapeutic options remain limited. Emerging evidence highlights the critical role of non-coding RNAs (ncRNAs) in…

  5. Artikel Jurnal Teks lengkap

    Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma

    Caecilia H. C. Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli dkk.

    Biomedicines, Vol. 9 No. 1 · 2021 · Inggris · DOAJ Scopus

    Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death worldwide, partially due to late diagnosis of the disease. Growing evidence in the field of biomarker discovery has shown the promising use of nucleic acid in the early detection of many cancers, including HCC…

  6. Artikel Jurnal

    Subtype-dependent PD-L1 stability and immune context shape immunotherapy response in hepatocellular carcinoma

    Luca Grisetti; Clarissa J. C. Garcia; Paola Tarchi dkk.

    Frontiers in Immunology, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    IntroductionImmune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis have expanded treatment options for hepatocellular carcinoma (HCC), yet only a subset of patients achieves durable responses. Limited efficacy reflects gaps in understanding PD-L1 regulation, including its biochemical…

  7. Artikel Jurnal Teks lengkap

    Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia

    John Paul Llido; Emanuela Fioriti; Devis Pascut dkk.

    Biology, Vol. 12 No. 6 · 2023 · Inggris · DOAJ Scopus

    Recent findings indicated aberrant epigenetic control of the central nervous system (CNS) development in hyperbilirubinemic Gunn rats as an additional cause of cerebellar hypoplasia, the landmark of bilirubin neurotoxicity in rodents. Because the symptoms in severely hyperbilirubinemic human…

  8. Artikel Jurnal

    Differences in circulating microRNA signature in Prader–Willi syndrome and non-syndromic obesity

    Devis Pascut; Sofia Tamini; Silvia Bresolin dkk.

    Endocrine Connections, Vol. 7 No. 12 · 2018 · Inggris · DOAJ Scopus

    Prader–Willi syndrome (PWS) represents the most common genetic-derived obesity disorder caused by the loss of expression of genes located on the paternal chromosome 15q11.2-q13. The PWS phenotype shows peculiar physical, endocrine and metabolic characteristics compared to those observed in…

  9. Artikel Jurnal

    MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma

    Luca Grisetti; Niệm Văn Thành Võ; Như Nhật Quỳnh Nguyễn dkk.

    Technology in Cancer Research & Treatment, Vol. 21 · 2022 · Inggris · DOAJ Scopus

    Background: Hepatic resection, radiofrequency ablation (RF), and liver transplantation (LT) represent the only available curative treatments for early stage hepatocellular carcinoma (HCC). Various studies showed that the 5-year overall survival (OS) rate reaches ∼70% after resection and ∼60% after…

  10. Artikel Jurnal

    Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome

    Devis Pascut; Pablo J. Giraudi; Cristina Banfi dkk.

    Frontiers in Endocrinology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    IntroductionPrader-Willi syndrome (PWS) is a rare genetic disorder characterized by loss of expression of paternal chromosome 15q11.2-q13 genes. Individuals with PWS exhibit unique physical, endocrine, and metabolic traits associated with severe obesity. Identifying liver steatosis in PWS is…

  11. Artikel Jurnal Teks lengkap

    MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View

    Alessandro Marco Bozzato; Paola Martingano; Roberta Antea Pozzi Mucelli dkk.

    Diagnostics, Vol. 12 No. 2 · 2022 · Inggris · DOAJ Scopus

    Hepatocellular Carcinoma (HCC) is the sixth most common cancer in the world. Patients with intermediate stage (Barcelona Clinic Liver Cancer, B stage) hepatocellular carcinoma (HCC) have been able to benefit from TACE (transarterial chemoembolization) as a treatment option. MicroRNAs (miRNAs)…